Genotype-guided use of oral antithrombotic therapy: a pharmacoeconomic perspective

Personalized Medicine
Taylor Sweezy, Shaker A Mousa

Abstract

Pharmacogenomics focuses on tailoring therapy to the individual as opposed to the historical model of fitting the individual to the therapy, and it offers the potential to maximize medication efficacy while reducing adverse events. By its very nature, personalized medicine is conducive to a patient-centered care model. Oral antithrombotics as a class could benefit immensely from this type of approach because an imbalance of safety and efficacy in either direction can yield deadly consequences. Since the current healthcare climate in the USA requires thoughtful allocation of resources, pharmacoeconomic analysis has become critical for all stakeholders, and the adoption of new technologies hinges upon economic impact. This article summarizes the current state of genetics in oral antithrombotic therapy, including clinical relevance as well as cost-effectiveness from a US healthcare system perspective, and provides insight into the future of pharmacogenomics in treating and preventing thromboembolic disorders.

References

Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Jan 5, 2002·Journal of the American College of Cardiology·Deepak L BhattEric J Topol
Aug 13, 2003·Journal of Thrombosis and Thrombolysis·Mark W LinderRoland Valdes
Jun 3, 2005·The New England Journal of Medicine·Mark J RiederAllan E Rettie
Sep 9, 2005·The New England Journal of Medicine·Marcello Di NisioHarry R Büller
Sep 15, 2005·Clinical Medicine & Research·Michael A HillmanJames K Burmester
Nov 12, 2005·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Joseph T KingMark S Roberts
Jan 18, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jessica L Fayer RehmelBarbara J Ring
Feb 21, 2006·Lancet·Graeme J Hankey, John W Eikelboom
Aug 1, 2006·Health Policy and Planning·Franco Sassi
Oct 28, 2006·PharmacoEconomics·Milton C Weinstein
Nov 23, 2006·Clinical Pharmacology and Therapeutics·Dirk TaubertEdgar Schömig
Jul 11, 2007·Expert Review of Molecular Diagnostics·Mark G DobsonDavid E Barton
Nov 6, 2007·The New England Journal of Medicine·Stephen D WiviottUNKNOWN TRITON-TIMI 38 Investigators
Nov 9, 2007·Circulation·Jeffrey L AndersonUNKNOWN Couma-Gen Investigators
Oct 15, 2008·Human Molecular Genetics·Liewei Wang, Richard M Weinshilboum
Jan 10, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Lifei WangDonglu Zhang
Mar 24, 2009·Journal of General Internal Medicine·Kirsten Neudoerffer KangelarisJeffrey A Tice
Apr 25, 2009·Nature Reviews. Drug Discovery·Irena Melnikova
Sep 1, 2009·The New England Journal of Medicine·Lars WallentinMona Thorsén
Sep 12, 2009·Journal of the American College of Cardiology·Francisco MarínDominick J Angiolillo
Nov 3, 2009·Blood·David GarciaMark A Crowther
Nov 21, 2009·JACC. Cardiovascular Interventions·Patrick GladdingMark Webster
Dec 8, 2009·The New England Journal of Medicine·Sam SchulmanUNKNOWN RE-COVER Study Group
Dec 25, 2009·Circulation. Cardiovascular Quality and Outcomes·Amanda R PatrickNiteesh K Choudhry
Mar 9, 2010·Current Pharmaceutical Design·Tom Schalekamp, Anthonius de Boer
Apr 13, 2010·Journal of the American College of Cardiology·Robert S EpsteinJ Russell Teagarden
May 14, 2010·Future Cardiology·Richard L SeipGualberto Ruaño
Jun 17, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Renli TengKathleen Butler
Aug 10, 2010·Clinical Trials : Journal of the Society for Clinical Trials·Jungnam JooJonas H Ellenberg
Oct 23, 2010·JACC. Cardiovascular Interventions·Patrick GladdingStephen Ellis
May 25, 2011·Circulation·Shimoli V Shah, Brian F Gage

❮ Previous
Next ❯

Citations

Jun 4, 2016·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Gary E MarchantDoug Campos-Outcalt
Jan 20, 2019·Journal of Personalized Medicine·Sri H Kanuri, Rolf P Kreutz

❮ Previous
Next ❯

Methods Mentioned

BETA
acetylation
genotyping

Software Mentioned

Gene
ARISTOTLE
EU
COAG
PACT
POPGenetics
GIFT

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.